Coherus BioSciences: Q4 Earnings Snapshot

REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Coherus BioSciences Inc. (CHRS) on Monday reported a loss of $58.9 million in its fourth quarter.

On a per-share basis, the Redwood City, California-based company said it had a loss of 76 cents. Losses, adjusted for stock option expense, came to 60 cents per share.

The drug developer posted revenue of $45.4 million in the period.

For the year, the company reported that its loss widened to $291.8 million, or $3.76 per share. Revenue was reported as $211 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on CHRS at

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up